Interleukin-5 and eosinophils as therapeutic targets for asthma

Trends in Molecular Medicine

Volumn 8, Issue 4, 2002, Pages 162-167

  Foster, Paul S ^a   Hogan, Simon P ^a   Yang, Ming ^a   Mattes, Joerg ^a   Young, Ian G ^a   Matthaei, Klaus I ^a   Kumar, Rakesh K ^b   Mahalingam, Surendran ^a   Webb, Dianne C ^a  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY;

ASTHMA; BRONCHUS HYPERREACTIVITY; CELL MIGRATION; CHRONIC DISEASE; CYTOKINE PRODUCTION; DISEASE MODEL; EOSINOPHILIA; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; TREATMENT FAILURE;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; EOSINOPHILIA; EOSINOPHILS; HUMANS; INTERLEUKIN-5; LUNG; MODELS, BIOLOGICAL;

ANIMALIA; BRONCHUS;

EID: 0036216507     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02302-X     Document Type: Review

References (64)

1. Immunological aspects of allergic asthma
2. Immunological basis of antigen-induced airways hyperresponsiveness
3. Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells
4. Sorting out the cytokines of asthma
5. Bronchial hyperreactivity and eosinophil granule proteins
6. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
7. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
8. Identification of Tlymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness
9. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics
10. Eosinophilic inflammation is associated with elevation ofinterleukin-5 in the airways of patients with spontaneous symptomatic asthma
11. Allergen challenge in asthma: Association of eosinophils and lymphocytes with interleukin-5
12. The immediate and late allergic response to segmental bronchopulmonary provocation in asthma
13. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
14. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
15. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
16. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
17. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
18. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium
19. The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivity
20. The role of eosinophils in the pathogenesis of asthma
21. The eosinophil and bronchial asthma: Current understanding
22. Eosinophilia
23. Cytotoxic properties of the eosinophil major basic protein
24. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils
25. The inflammatory response in asthma exacerbation: Changes in circulating eosinophils, basophils and their progenitors
26. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors
27. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects
28. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice
29. Peripheral blood basophils, basophil progenitors, and nasal metachromatic cells in allergic rhinitis
30. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow·derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation
31. Allergen challenge increases cell traffic between bone marrow and lung
32. Bone marrow contribution to eosinophilic inflammation
33. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells
34. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice
35. Interleukin (IL)-5 but not immunoglobulin E reconstitutes airway inflammation and airway hyperresponsiveness in IL-4-deficient mice
36. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes
37. Effect of murine recombinant interleukin-5 on bronchial reactivity in guinea-pigs
38. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma
39. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
40. The trials and tribulations of IL-5, eosinophils, and allergic asthma
41. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity
42. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GMCSF
43. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5)
44. Recombinant human interleukin 5 is a selective activator of human eosinophil function
45. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
46. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
47. + T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice
48. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
49. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
50. Elemental signals regulating eosinophil accumulation in the lung
51. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/ interleukin-5 functions
52. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
53. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice
54. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness
55. The allergen-induced airway hyperresponsiveness in a human-mouse chimera model of asthma is T cell and IL-4 and IL-5 dependent
56. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma
57. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma
58. Eosinophilia, parasite burden and lung damage in Toxocara canis infection in C57B1/6 mice genetically deficient in IL-5
59. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation
60. Murine model of chronic human asthma
61. Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma
62. An improved murine model of asthma: Selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen
63. Uterine eosinophils and reproductive performance in interleukin 5-deficient mice
64. Cellular and molecular regulation of eosinophil trafficking to the lung